Polypharmacy integration with medication appropriateness index

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: WU, Tien-Yuan (Tzu Chi University, Pharmacology, Hualien, China Taiwan)
  • Co-author(s): Ya-Ling Ko: Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan, Province of China
    Tien-Yuan Wu: Pharmacology, Tzu Chi University, Hualien, Taiwan, Province of China;Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan, Province of China
    Hui-Hsia Hsieh: Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan, Province of China
    Chi-Hua Chen: Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan, Province of China
  • Abstract:

    Background

    Polypharmacy is administering four or more medicines for a patient, especially treating the coexisting conditions, and may result in adverse drug reactions and interactions. A primary pharmacist can integrate elder citizens' medications to reduce the risk of drug-drug interactions. It also has benefits to reduce the medical expenses.

    Purpo..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login